{"id":11280,"date":"2023-10-31T17:04:10","date_gmt":"2023-10-31T17:04:10","guid":{"rendered":"https:\/\/maat.swebwp.oci.eu\/?p=11280"},"modified":"2023-10-31T17:04:10","modified_gmt":"2023-10-31T17:04:10","slug":"31-octobre-2023-maat-pharma-presente-des-donnees-precliniques-au-sitc-pour-maat034-produit-genere-par-intelligence-artificielle-pour-ameliorer-les-reponses-des-patients-aux-immunotherapies","status":"publish","type":"post","link":"https:\/\/maat.swebwp.oci.eu\/fr\/31-octobre-2023-maat-pharma-presente-des-donnees-precliniques-au-sitc-pour-maat034-produit-genere-par-intelligence-artificielle-pour-ameliorer-les-reponses-des-patients-aux-immunotherapies\/","title":{"rendered":"31 octobre 2023 : MaaT Pharma pr\u00e9sente des donn\u00e9es pr\u00e9cliniques au SITC pour MaaT034, produit g\u00e9n\u00e9r\u00e9 par intelligence artificielle pour am\u00e9liorer les r\u00e9ponses des patients aux immunoth\u00e9rapies"},"content":{"rendered":"[vc_row type=\u00a0\u00bbin_container\u00a0\u00bb full_screen_row_position=\u00a0\u00bbmiddle\u00a0\u00bb column_margin=\u00a0\u00bbdefault\u00a0\u00bb column_direction=\u00a0\u00bbdefault\u00a0\u00bb column_direction_tablet=\u00a0\u00bbdefault\u00a0\u00bb column_direction_phone=\u00a0\u00bbdefault\u00a0\u00bb scene_position=\u00a0\u00bbcenter\u00a0\u00bb text_color=\u00a0\u00bbdark\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb row_border_radius=\u00a0\u00bbnone\u00a0\u00bb row_border_radius_applies=\u00a0\u00bbbg\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb shape_divider_position=\u00a0\u00bbbottom\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb][vc_column column_padding=\u00a0\u00bbno-extra-padding\u00a0\u00bb column_padding_tablet=\u00a0\u00bbinherit\u00a0\u00bb column_padding_phone=\u00a0\u00bbinherit\u00a0\u00bb column_padding_position=\u00a0\u00bball\u00a0\u00bb column_element_spacing=\u00a0\u00bbdefault\u00a0\u00bb background_color_opacity=\u00a0\u00bb1&Prime; background_hover_color_opacity=\u00a0\u00bb1&Prime; column_shadow=\u00a0\u00bbnone\u00a0\u00bb column_border_radius=\u00a0\u00bbnone\u00a0\u00bb column_link_target=\u00a0\u00bb_self\u00a0\u00bb gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; width=\u00a0\u00bb1\/6&Prime; tablet_width_inherit=\u00a0\u00bbdefault\u00a0\u00bb tablet_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb phone_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb border_type=\u00a0\u00bbsimple\u00a0\u00bb column_border_width=\u00a0\u00bbnone\u00a0\u00bb column_border_style=\u00a0\u00bbsolid\u00a0\u00bb][\/vc_column][vc_column column_padding=\u00a0\u00bbno-extra-padding\u00a0\u00bb column_padding_tablet=\u00a0\u00bbinherit\u00a0\u00bb column_padding_phone=\u00a0\u00bbinherit\u00a0\u00bb column_padding_position=\u00a0\u00bball\u00a0\u00bb column_element_spacing=\u00a0\u00bbdefault\u00a0\u00bb background_color_opacity=\u00a0\u00bb1&Prime; background_hover_color_opacity=\u00a0\u00bb1&Prime; column_shadow=\u00a0\u00bbnone\u00a0\u00bb column_border_radius=\u00a0\u00bbnone\u00a0\u00bb column_link_target=\u00a0\u00bb_self\u00a0\u00bb gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; width=\u00a0\u00bb2\/3&Prime; tablet_width_inherit=\u00a0\u00bbdefault\u00a0\u00bb tablet_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb phone_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb border_type=\u00a0\u00bbsimple\u00a0\u00bb column_border_width=\u00a0\u00bbnone\u00a0\u00bb column_border_style=\u00a0\u00bbsolid\u00a0\u00bb][vc_column_text]\n<h3 style=\"text-align: center;\"><span style=\"color: #283583;\">MaaT Pharma pr\u00e9sente des donn\u00e9es pr\u00e9cliniques au SITC pour MaaT034, produit g\u00e9n\u00e9r\u00e9 par intelligence artificielle pour am\u00e9liorer les r\u00e9ponses des patients aux immunoth\u00e9rapies<\/span><\/h3>\n[\/vc_column_text][vc_column_text]\n<ul>\n<li>Pr\u00e9sentation de la strat\u00e9gie de s\u00e9lection bas\u00e9e sur l\u2019IA d\u00e9velopp\u00e9e pour identifier une nouvelle g\u00e9n\u00e9ration de candidats-m\u00e9dicaments, dont MaaT034 est le premier produit de cette nouvelle gamme.<\/li>\n<li>Premi\u00e8re pr\u00e9sentation de donn\u00e9es <em>in vitro<\/em> pour MaaT034, une nouvelle g\u00e9n\u00e9ration de produit, d\u00e9montrant des activit\u00e9s biologiques qui am\u00e9liorent les r\u00e9ponses aux traitements par Inhibiteurs de points de Contr\u00f4le Immunitaire (ICI).<\/li>\n<\/ul>\n[\/vc_column_text][\/vc_column][vc_column column_padding=\u00a0\u00bbno-extra-padding\u00a0\u00bb column_padding_tablet=\u00a0\u00bbinherit\u00a0\u00bb column_padding_phone=\u00a0\u00bbinherit\u00a0\u00bb column_padding_position=\u00a0\u00bball\u00a0\u00bb column_element_spacing=\u00a0\u00bbdefault\u00a0\u00bb background_color_opacity=\u00a0\u00bb1&Prime; background_hover_color_opacity=\u00a0\u00bb1&Prime; column_shadow=\u00a0\u00bbnone\u00a0\u00bb column_border_radius=\u00a0\u00bbnone\u00a0\u00bb column_link_target=\u00a0\u00bb_self\u00a0\u00bb gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; width=\u00a0\u00bb1\/6&Prime; tablet_width_inherit=\u00a0\u00bbdefault\u00a0\u00bb tablet_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb phone_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb border_type=\u00a0\u00bbsimple\u00a0\u00bb column_border_width=\u00a0\u00bbnone\u00a0\u00bb column_border_style=\u00a0\u00bbsolid\u00a0\u00bb][\/vc_column][\/vc_row][vc_row type=\u00a0\u00bbin_container\u00a0\u00bb full_screen_row_position=\u00a0\u00bbmiddle\u00a0\u00bb column_margin=\u00a0\u00bbdefault\u00a0\u00bb column_direction=\u00a0\u00bbdefault\u00a0\u00bb column_direction_tablet=\u00a0\u00bbdefault\u00a0\u00bb column_direction_phone=\u00a0\u00bbdefault\u00a0\u00bb scene_position=\u00a0\u00bbcenter\u00a0\u00bb text_color=\u00a0\u00bbdark\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb row_border_radius=\u00a0\u00bbnone\u00a0\u00bb row_border_radius_applies=\u00a0\u00bbbg\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb shape_divider_position=\u00a0\u00bbbottom\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb][vc_column column_padding=\u00a0\u00bbno-extra-padding\u00a0\u00bb column_padding_tablet=\u00a0\u00bbinherit\u00a0\u00bb column_padding_phone=\u00a0\u00bbinherit\u00a0\u00bb column_padding_position=\u00a0\u00bball\u00a0\u00bb column_element_spacing=\u00a0\u00bbdefault\u00a0\u00bb background_color_opacity=\u00a0\u00bb1&Prime; background_hover_color_opacity=\u00a0\u00bb1&Prime; column_shadow=\u00a0\u00bbnone\u00a0\u00bb column_border_radius=\u00a0\u00bbnone\u00a0\u00bb column_link_target=\u00a0\u00bb_self\u00a0\u00bb gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; width=\u00a0\u00bb1\/6&Prime; tablet_width_inherit=\u00a0\u00bbdefault\u00a0\u00bb tablet_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb phone_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb border_type=\u00a0\u00bbsimple\u00a0\u00bb column_border_width=\u00a0\u00bbnone\u00a0\u00bb column_border_style=\u00a0\u00bbsolid\u00a0\u00bb][\/vc_column][vc_column column_padding=\u00a0\u00bbno-extra-padding\u00a0\u00bb column_padding_tablet=\u00a0\u00bbinherit\u00a0\u00bb column_padding_phone=\u00a0\u00bbinherit\u00a0\u00bb column_padding_position=\u00a0\u00bball\u00a0\u00bb column_element_spacing=\u00a0\u00bbdefault\u00a0\u00bb background_color_opacity=\u00a0\u00bb1&Prime; background_hover_color_opacity=\u00a0\u00bb1&Prime; column_shadow=\u00a0\u00bbnone\u00a0\u00bb column_border_radius=\u00a0\u00bbnone\u00a0\u00bb column_link_target=\u00a0\u00bb_self\u00a0\u00bb gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; width=\u00a0\u00bb2\/3&Prime; tablet_width_inherit=\u00a0\u00bbdefault\u00a0\u00bb tablet_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb phone_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb border_type=\u00a0\u00bbsimple\u00a0\u00bb column_border_width=\u00a0\u00bbnone\u00a0\u00bb column_border_style=\u00a0\u00bbsolid\u00a0\u00bb][vc_column_text]<strong><span style=\"color: #283583;\">Lyon, France, 31 octobre 2023 \u2013 18h00 CET \u2013 <\/span><\/strong><a href=\"https:\/\/maat.swebwp.oci.eu\/fr\/\"><strong>MaaT Pharma<\/strong><\/a><strong> <span style=\"color: #283583;\">(EURONEXT\u00a0: MAAT &#8211; la \u00ab\u00a0Soci\u00e9t\u00e9\u00a0\u00bb), soci\u00e9t\u00e9 de biotechnologies en stade clinique avanc\u00e9, leader dans le d\u00e9veloppement de Microbiome Ecosystem Therapies<sup>TM<\/sup> (MET)<a href=\"#_edn1\" name=\"_ednref1\"><sup>[1]<\/sup><\/a> visant \u00e0 am\u00e9liorer la survie des patients atteints de cancers, <\/span><\/strong>annonce aujourd&rsquo;hui les d\u00e9tails des deux posters qui seront pr\u00e9sent\u00e9s lors de la <a href=\"https:\/\/www.sitcancer.org\/2023\/home\">38<sup>\u00e8me<\/sup> conf\u00e9rence annuelle de la Society for Immunotherapy of Cancer (SITC),<\/a> \u00e9v\u00e9nement mondial de premier plan en immunoth\u00e9rapie, qui se tiendra du 1<sup>er<\/sup> au 5 novembre 2023 \u00e0 San Diego, en Californie, aux \u00c9tats-Unis. Les pr\u00e9sentations incluront les r\u00e9sultats <em>in vitro<\/em> de son premier produit, MaaT034, g\u00e9n\u00e9r\u00e9 par Intelligence Artificielle (IA), d\u00e9di\u00e9 \u00e0 am\u00e9liorer la r\u00e9ponse des patients aux immunoth\u00e9rapies dans les tumeurs solides. MaaT034 est le premier produit issu de la plateforme MET-C, capable de reproduire gr\u00e2ce \u00e0 la co-culture un \u00e9cosyst\u00e8me microbiote sain. Le premier essai sur l&rsquo;homme est pr\u00e9vu pour 2025, avec les premiers lots cliniques produits en 2024.<\/p>\n<p><strong>Nathalie Corvaia, directrice scientifique, a d\u00e9clar\u00e9 :<\/strong> <em>\u00ab\u00a0Nous sommes tr\u00e8s fiers de pr\u00e9senter nos premi\u00e8res donn\u00e9es pr\u00e9cliniques lors du SITC, d\u00e9montrant des activit\u00e9s biologiques pour MaaT034, notre nouvelle g\u00e9n\u00e9ration de produits co-cultiv\u00e9s, et la robustesse de notre outil propri\u00e9taire d\u2019IA, gutPrint\u00ae. MaaT034 a montr\u00e9 \u00eatre actif pour restaurer l&rsquo;int\u00e9grit\u00e9 de la barri\u00e8re intestinale et pour stimuler les cellules immunitaires, entra\u00eenant une am\u00e9lioration de la r\u00e9ponse des cellules immunitaires \u00e0 la th\u00e9rapie par ICI. Cela renforce notre confiance dans notre approche en immuno-oncologie pilot\u00e9e par notre outil d&rsquo;IA. Nous sommes impatients de passer \u00e0 l&rsquo;\u00e9valuation clinique en 2025.\u00a0\u00bb<\/em><\/p>\n<p><strong>D\u00e9tails des pr\u00e9sentations des posters\u00a0:<br \/>\n<\/strong><strong>Poster 1 Titre :<\/strong> <a href=\"https:\/\/jitc.bmj.com\/content\/11\/Suppl_1\/1472\">Evaluation of a new co-cultured microbiome ecosystem therapy candidate (MaaT03X) for clinical testing as adjuvant\/neoadjuvant to immune checkpoint inhibitors in solid tumors<\/a><br \/>\nNum\u00e9ro de poster : 1321<br \/>\nDate et lieu : 3 novembre 2023 \u2013 Exhibit Halls A &amp; B1<br \/>\nPrincipaux r\u00e9sultats pour MaaT034 :<\/p>\n<ul>\n<li><em>reproduit, \u00e0 grande \u00e9chelle industrielle, la richesse et la diversit\u00e9 des \u00e9cosyst\u00e8mes microbiens sains d&rsquo;origine <\/em><\/li>\n<li><em>restaure l&rsquo;int\u00e9grit\u00e9 d&rsquo;une barri\u00e8re intestinale endommag\u00e9e <\/em><\/li>\n<li><em>active la voie AhR<a href=\"#_ednref2\" name=\"_edn2\"><strong><sup>[2]<\/sup><\/strong><\/a> impliqu\u00e9e dans l&rsquo;hom\u00e9ostasie intestinale <\/em><\/li>\n<li><em>stimule \u00e0 la fois les cellules immunitaires my\u00e9lo\u00efdes et lympho\u00efdes <\/em><\/li>\n<li><em>am\u00e9liore la r\u00e9ponse des cellules immunitaires \u00e0 la th\u00e9rapie par ICI<\/em><\/li>\n<\/ul>\n<p><strong>Poster 2 Titre :<\/strong> <a href=\"https:\/\/jitc.bmj.com\/content\/11\/Suppl_1\/1449\">Robust Machine Learning (ML) approach for screening Microbiome Ecosystem Therapies (MET) drug candidates in combination with Immune Checkpoint Inhibitors<\/a><br \/>\nNum\u00e9ro de poster : 1304<br \/>\nDate et lieu : 3 novembre 2023 \u2013 Exhibit Halls A &amp; B1<br \/>\nPrincipaux r\u00e9sultats pour l\u2019outil gutPrint\u00ae AI :<\/p>\n<ul>\n<li><em>S\u00e9lection et entra\u00eenement de mod\u00e8les pour \u00e9valuer les \u00e9chantillons comme \u00ab\u00a0Responder-like\u00a0\u00bb selon la m\u00e9tag\u00e9nomique f\u00e9cale de base des patients atteints de cancer trait\u00e9s par ICI<\/em><\/li>\n<li><em>Am\u00e9lioration des performances pr\u00e9dictives par rapport \u00e0 la litt\u00e9rature avec plus de donn\u00e9es patients, des \u00e9tudes crois\u00e9es et des indications<\/em><\/li>\n<li><em>L&rsquo;application du mod\u00e8le le plus performant (LODO AUC moyen = 0,65) \u00e0 la cohorte de donneurs sains de MaaT Pharma ou aux \u00e9chantillons \u00ab\u00a0pool\u00e9s\u00a0\u00bb (m\u00e9langes de selles de 4 \u00e0 8 donneurs sains) a class\u00e9 une grande majorit\u00e9 d&rsquo;entre eux comme microbiote \u00ab\u00a0Responder-like\u00a0\u00bb (surtout les \u00e9chantillons \u00ab\u00a0pool\u00e9s\u00a0\u00bb)<\/em><\/li>\n<\/ul>\n<h5><a href=\"#_ednref1\" name=\"_edn1\"><em><strong><sup>[1]<\/sup><\/strong><\/em><\/a> <em>Microbiome Ecosystem Therapy<sup>TM<\/sup>: Microbioth\u00e9rapie \u00e0 Ecosyst\u00e8me Complet<\/em><br \/>\n<a href=\"#_ednref2\" name=\"_edn2\"><\/a><\/h5>\n<h5><em><a href=\"#_ednref2\" name=\"_edn2\"><strong><sup>[2]<\/sup><\/strong><\/a> AhR: Aryl Hydrocarbon Receptor &#8211; r\u00e9cepteur d&rsquo;<\/em>aryl hydrocarbone<\/h5>\n[\/vc_column_text][\/vc_column][vc_column column_padding=\u00a0\u00bbno-extra-padding\u00a0\u00bb column_padding_tablet=\u00a0\u00bbinherit\u00a0\u00bb column_padding_phone=\u00a0\u00bbinherit\u00a0\u00bb column_padding_position=\u00a0\u00bball\u00a0\u00bb column_element_spacing=\u00a0\u00bbdefault\u00a0\u00bb background_color_opacity=\u00a0\u00bb1&Prime; background_hover_color_opacity=\u00a0\u00bb1&Prime; column_shadow=\u00a0\u00bbnone\u00a0\u00bb column_border_radius=\u00a0\u00bbnone\u00a0\u00bb column_link_target=\u00a0\u00bb_self\u00a0\u00bb gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; width=\u00a0\u00bb1\/6&Prime; tablet_width_inherit=\u00a0\u00bbdefault\u00a0\u00bb tablet_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb phone_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb border_type=\u00a0\u00bbsimple\u00a0\u00bb column_border_width=\u00a0\u00bbnone\u00a0\u00bb column_border_style=\u00a0\u00bbsolid\u00a0\u00bb][\/vc_column][\/vc_row][vc_row type=\u00a0\u00bbin_container\u00a0\u00bb full_screen_row_position=\u00a0\u00bbmiddle\u00a0\u00bb column_margin=\u00a0\u00bbdefault\u00a0\u00bb column_direction=\u00a0\u00bbdefault\u00a0\u00bb column_direction_tablet=\u00a0\u00bbdefault\u00a0\u00bb column_direction_phone=\u00a0\u00bbdefault\u00a0\u00bb scene_position=\u00a0\u00bbcenter\u00a0\u00bb text_color=\u00a0\u00bbdark\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb row_border_radius=\u00a0\u00bbnone\u00a0\u00bb row_border_radius_applies=\u00a0\u00bbbg\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb shape_divider_position=\u00a0\u00bbbottom\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb][vc_column column_padding=\u00a0\u00bbno-extra-padding\u00a0\u00bb column_padding_tablet=\u00a0\u00bbinherit\u00a0\u00bb column_padding_phone=\u00a0\u00bbinherit\u00a0\u00bb column_padding_position=\u00a0\u00bball\u00a0\u00bb column_element_spacing=\u00a0\u00bbdefault\u00a0\u00bb background_color_opacity=\u00a0\u00bb1&Prime; background_hover_color_opacity=\u00a0\u00bb1&Prime; column_shadow=\u00a0\u00bbnone\u00a0\u00bb column_border_radius=\u00a0\u00bbnone\u00a0\u00bb column_link_target=\u00a0\u00bb_self\u00a0\u00bb gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; width=\u00a0\u00bb1\/6&Prime; tablet_width_inherit=\u00a0\u00bbdefault\u00a0\u00bb tablet_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb phone_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb border_type=\u00a0\u00bbsimple\u00a0\u00bb column_border_width=\u00a0\u00bbnone\u00a0\u00bb column_border_style=\u00a0\u00bbsolid\u00a0\u00bb][\/vc_column][vc_column column_padding=\u00a0\u00bbno-extra-padding\u00a0\u00bb column_padding_tablet=\u00a0\u00bbinherit\u00a0\u00bb column_padding_phone=\u00a0\u00bbinherit\u00a0\u00bb column_padding_position=\u00a0\u00bball\u00a0\u00bb column_element_spacing=\u00a0\u00bbdefault\u00a0\u00bb background_color_opacity=\u00a0\u00bb1&Prime; background_hover_color_opacity=\u00a0\u00bb1&Prime; column_shadow=\u00a0\u00bbnone\u00a0\u00bb column_border_radius=\u00a0\u00bbnone\u00a0\u00bb column_link_target=\u00a0\u00bb_self\u00a0\u00bb gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; width=\u00a0\u00bb2\/3&Prime; tablet_width_inherit=\u00a0\u00bbdefault\u00a0\u00bb tablet_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb phone_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb border_type=\u00a0\u00bbsimple\u00a0\u00bb column_border_width=\u00a0\u00bbnone\u00a0\u00bb column_border_style=\u00a0\u00bbsolid\u00a0\u00bb][vc_column_text]<span style=\"color: #283583;\"><strong>A propos de MaaT Pharma<\/strong><\/span><\/p>\n<p>MaaT Pharma est une soci\u00e9t\u00e9 de biotechnologies au stade clinique qui a mis au point une approche compl\u00e8te pour restaurer la symbiose microbiote\/h\u00f4te des patients atteints de cancers. Engag\u00e9e dans le traitement des cancers et de la maladie du greffon contre l\u2019h\u00f4te (GvH), une complication grave survenant apr\u00e8s une greffe de cellules souches h\u00e9matopo\u00ef\u00e9tiques, MaaT Pharma a lanc\u00e9 en mars 2022 en Europe un essai clinique de Phase 3 chez des patients atteints de GvH aigu\u00eb, apr\u00e8s avoir r\u00e9alis\u00e9 la preuve de concept de son approche dans un essai clinique de Phase 2. Sa puissante plateforme de d\u00e9couverte et d\u2019analyse, gutPrint\u00ae soutient le d\u00e9veloppement de son portefeuille de produits et son extension \u00e0 des indications plus larges, en aidant \u00e0 d\u00e9terminer de nouvelles cibles th\u00e9rapeutiques, \u00e0 \u00e9valuer les m\u00e9dicaments candidats et \u00e0 identifier des biomarqueurs pour la prise en charge de pathologies impliquant le microbiote. Les <em>Microbiome Ecosystem Therapies<sup>TM <\/sup><\/em>(Microbioth\u00e9rapies \u00e0 \u00e9cosyst\u00e8me complet) sont toutes produites dans le cadre tr\u00e8s standardis\u00e9 d\u2019une fabrication et de contr\u00f4les qualit\u00e9 cGMP, afin de garantir en toute s\u00e9curit\u00e9 l\u2019acc\u00e8s \u00e0 la diversit\u00e9 et \u00e0 la richesse du microbiote, sous forme orale ou d\u2019<em>enema<\/em>. MaaT Pharma b\u00e9n\u00e9ficie de l\u2019engagement de scientifiques de renomm\u00e9e mondiale et de relations \u00e9tablies avec les instances r\u00e9glementaires pour faire progresser l\u2019int\u00e9gration des th\u00e9rapies \u00e0 base de microbiote dans la pratique clinique.<\/p>\n<p>MaaT Pharma est la premi\u00e8re soci\u00e9t\u00e9 d\u00e9veloppant des m\u00e9dicaments \u00e0 base de microbiote cot\u00e9e sur Euronext Paris (Code mn\u00e9monique\u00a0: MAAT).[\/vc_column_text][image_with_animation image_url=\u00a0\u00bb6212&Prime; animation=\u00a0\u00bbFade In\u00a0\u00bb hover_animation=\u00a0\u00bbnone\u00a0\u00bb alignment=\u00a0\u00bbcenter\u00a0\u00bb border_radius=\u00a0\u00bbnone\u00a0\u00bb box_shadow=\u00a0\u00bbnone\u00a0\u00bb image_loading=\u00a0\u00bbdefault\u00a0\u00bb max_width=\u00a0\u00bb100%\u00a0\u00bb max_width_mobile=\u00a0\u00bbdefault\u00a0\u00bb][vc_column_text]<span style=\"color: #283583;\"><strong>Donn\u00e9es prospectives<\/strong><\/span><\/p>\n<p>Ce communiqu\u00e9 de presse contient des d\u00e9clarations prospectives. Toutes les d\u00e9clarations autres que les \u00e9nonc\u00e9s de faits historiques inclus dans le pr\u00e9sent communiqu\u00e9 de presse au sujet d&rsquo;\u00e9v\u00e9nements futurs sont sujettes \u00e0 (i) des changements sans pr\u00e9avis et (ii) des facteurs ind\u00e9pendants de la volont\u00e9 de la Soci\u00e9t\u00e9. Ces d\u00e9clarations peuvent comprendre, sans s&rsquo;y limiter, tout \u00e9nonc\u00e9 pr\u00e9c\u00e9d\u00e9, suivi ou incluant des mots tels que \u00ab cibler \u00bb, \u00ab croire \u00bb, \u00ab s&rsquo;attendre \u00e0 \u00bb, \u00ab viser \u00bb, \u00ab avoir l&rsquo;intention de \u00bb, \u00ab pouvoir \u00bb, \u00ab pr\u00e9voir \u00bb, \u00ab estimer \u00bb, \u00ab planifier \u00bb, \u00ab projeter \u00bb, \u00ab vouloir \u00bb, \u00ab pouvoir avoir \u00bb, \u00ab susceptible de \u00bb, \u00ab probable \u00bb, \u00ab devoir \u00bb, \u00ab pr\u00e9visions \u00bb et d\u2019autres mots et termes ayant un sens similaire ou la forme n\u00e9gative qui en d\u00e9coule. Les d\u00e9clarations prospectives sont assujetties \u00e0 des risques et \u00e0 des incertitudes inh\u00e9rentes ind\u00e9pendants de la volont\u00e9 de la Soci\u00e9t\u00e9 qui pourraient conduire \u00e0 ce que les r\u00e9sultats ou les performances r\u00e9els de la Soci\u00e9t\u00e9 diff\u00e8rent consid\u00e9rablement des r\u00e9sultats ou des performances attendus exprim\u00e9s ou sous-entendus dans ces d\u00e9clarations prospectives.[\/vc_column_text][\/vc_column][\/vc_row][vc_row type=\u00a0\u00bbin_container\u00a0\u00bb full_screen_row_position=\u00a0\u00bbmiddle\u00a0\u00bb column_margin=\u00a0\u00bbdefault\u00a0\u00bb column_direction=\u00a0\u00bbdefault\u00a0\u00bb column_direction_tablet=\u00a0\u00bbdefault\u00a0\u00bb column_direction_phone=\u00a0\u00bbdefault\u00a0\u00bb scene_position=\u00a0\u00bbcenter\u00a0\u00bb text_color=\u00a0\u00bbdark\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb row_border_radius=\u00a0\u00bbnone\u00a0\u00bb row_border_radius_applies=\u00a0\u00bbbg\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb shape_divider_position=\u00a0\u00bbbottom\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb][vc_column column_padding=\u00a0\u00bbno-extra-padding\u00a0\u00bb column_padding_tablet=\u00a0\u00bbinherit\u00a0\u00bb column_padding_phone=\u00a0\u00bbinherit\u00a0\u00bb column_padding_position=\u00a0\u00bball\u00a0\u00bb column_element_spacing=\u00a0\u00bbdefault\u00a0\u00bb background_color_opacity=\u00a0\u00bb1&Prime; background_hover_color_opacity=\u00a0\u00bb1&Prime; column_shadow=\u00a0\u00bbnone\u00a0\u00bb column_border_radius=\u00a0\u00bbnone\u00a0\u00bb column_link_target=\u00a0\u00bb_self\u00a0\u00bb gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; width=\u00a0\u00bb1\/3&Prime; tablet_width_inherit=\u00a0\u00bbdefault\u00a0\u00bb tablet_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb phone_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb border_type=\u00a0\u00bbsimple\u00a0\u00bb column_border_width=\u00a0\u00bbnone\u00a0\u00bb column_border_style=\u00a0\u00bbsolid\u00a0\u00bb][\/vc_column][vc_column column_padding=\u00a0\u00bbno-extra-padding\u00a0\u00bb column_padding_tablet=\u00a0\u00bbinherit\u00a0\u00bb column_padding_phone=\u00a0\u00bbinherit\u00a0\u00bb column_padding_position=\u00a0\u00bball\u00a0\u00bb column_element_spacing=\u00a0\u00bbdefault\u00a0\u00bb background_color_opacity=\u00a0\u00bb1&Prime; background_hover_color_opacity=\u00a0\u00bb1&Prime; column_shadow=\u00a0\u00bbnone\u00a0\u00bb column_border_radius=\u00a0\u00bbnone\u00a0\u00bb column_link_target=\u00a0\u00bb_self\u00a0\u00bb gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; width=\u00a0\u00bb1\/3&Prime; tablet_width_inherit=\u00a0\u00bbdefault\u00a0\u00bb tablet_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb phone_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb border_type=\u00a0\u00bbsimple\u00a0\u00bb column_border_width=\u00a0\u00bbnone\u00a0\u00bb column_border_style=\u00a0\u00bbsolid\u00a0\u00bb][nectar_btn size=\u00a0\u00bblarge\u00a0\u00bb open_new_tab=\u00a0\u00bbtrue\u00a0\u00bb button_style=\u00a0\u00bbregular\u00a0\u00bb button_color_2=\u00a0\u00bbAccent-Color\u00a0\u00bb icon_family=\u00a0\u00bbnone\u00a0\u00bb text=\u00a0\u00bbT\u00e9l\u00e9charger le communiqu\u00e9 de presse\u00a0\u00bb url=\u00a0\u00bbhttps:\/\/maat.swebwp.oci.eu\/wp-content\/uploads\/2023\/10\/231031_FR_MaaT-Pharma_SITC-Pre\u0301sentations_FINAL.pdf\u00a0\u00bb][\/vc_column][vc_column column_padding=\u00a0\u00bbno-extra-padding\u00a0\u00bb column_padding_tablet=\u00a0\u00bbinherit\u00a0\u00bb column_padding_phone=\u00a0\u00bbinherit\u00a0\u00bb column_padding_position=\u00a0\u00bball\u00a0\u00bb column_element_spacing=\u00a0\u00bbdefault\u00a0\u00bb background_color_opacity=\u00a0\u00bb1&Prime; background_hover_color_opacity=\u00a0\u00bb1&Prime; column_shadow=\u00a0\u00bbnone\u00a0\u00bb column_border_radius=\u00a0\u00bbnone\u00a0\u00bb column_link_target=\u00a0\u00bb_self\u00a0\u00bb gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; width=\u00a0\u00bb1\/3&Prime; tablet_width_inherit=\u00a0\u00bbdefault\u00a0\u00bb tablet_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb phone_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb border_type=\u00a0\u00bbsimple\u00a0\u00bb column_border_width=\u00a0\u00bbnone\u00a0\u00bb column_border_style=\u00a0\u00bbsolid\u00a0\u00bb][\/vc_column][\/vc_row][vc_row type=\u00a0\u00bbin_container\u00a0\u00bb full_screen_row_position=\u00a0\u00bbmiddle\u00a0\u00bb column_margin=\u00a0\u00bbdefault\u00a0\u00bb column_direction=\u00a0\u00bbdefault\u00a0\u00bb column_direction_tablet=\u00a0\u00bbdefault\u00a0\u00bb column_direction_phone=\u00a0\u00bbdefault\u00a0\u00bb scene_position=\u00a0\u00bbcenter\u00a0\u00bb text_color=\u00a0\u00bbdark\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb row_border_radius=\u00a0\u00bbnone\u00a0\u00bb row_border_radius_applies=\u00a0\u00bbbg\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb shape_divider_position=\u00a0\u00bbbottom\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb][vc_column column_padding=\u00a0\u00bbno-extra-padding\u00a0\u00bb column_padding_tablet=\u00a0\u00bbinherit\u00a0\u00bb column_padding_phone=\u00a0\u00bbinherit\u00a0\u00bb column_padding_position=\u00a0\u00bball\u00a0\u00bb column_element_spacing=\u00a0\u00bbdefault\u00a0\u00bb background_color_opacity=\u00a0\u00bb1&Prime; background_hover_color_opacity=\u00a0\u00bb1&Prime; column_shadow=\u00a0\u00bbnone\u00a0\u00bb column_border_radius=\u00a0\u00bbnone\u00a0\u00bb column_link_target=\u00a0\u00bb_self\u00a0\u00bb gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; width=\u00a0\u00bb1\/1&Prime; tablet_width_inherit=\u00a0\u00bbdefault\u00a0\u00bb tablet_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb phone_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb border_type=\u00a0\u00bbsimple\u00a0\u00bb column_border_width=\u00a0\u00bbnone\u00a0\u00bb column_border_style=\u00a0\u00bbsolid\u00a0\u00bb][\/vc_column][\/vc_row]\n","protected":false},"excerpt":{"rendered":"<p>[vc_row type=\u00a0\u00bbin_container\u00a0\u00bb full_screen_row_position=\u00a0\u00bbmiddle\u00a0\u00bb column_margin=\u00a0\u00bbdefault\u00a0\u00bb column_direction=\u00a0\u00bbdefault\u00a0\u00bb column_direction_tablet=\u00a0\u00bbdefault\u00a0\u00bb column_direction_phone=\u00a0\u00bbdefault\u00a0\u00bb scene_position=\u00a0\u00bbcenter\u00a0\u00bb text_color=\u00a0\u00bbdark\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb row_border_radius=\u00a0\u00bbnone\u00a0\u00bb row_border_radius_applies=\u00a0\u00bbbg\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb shape_divider_position=\u00a0\u00bbbottom\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb][vc_column column_padding=\u00a0\u00bbno-extra-padding\u00a0\u00bb column_padding_tablet=\u00a0\u00bbinherit\u00a0\u00bb column_padding_phone=\u00a0\u00bbinherit\u00a0\u00bb column_padding_position=\u00a0\u00bball\u00a0\u00bb column_element_spacing=\u00a0\u00bbdefault\u00a0\u00bb background_color_opacity=\u00a0\u00bb1&Prime; background_hover_color_opacity=\u00a0\u00bb1&Prime; column_shadow=\u00a0\u00bbnone\u00a0\u00bb column_border_radius=\u00a0\u00bbnone\u00a0\u00bb column_link_target=\u00a0\u00bb_self\u00a0\u00bb gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; width=\u00a0\u00bb1\/6&Prime; tablet_width_inherit=\u00a0\u00bbdefault\u00a0\u00bb&#8230;<\/p>\n","protected":false},"author":2,"featured_media":7120,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[21],"tags":[37,40,39],"category_press":[67],"year_press":[47],"class_list":{"0":"post-11280","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-communiques-de-presse-fr","8":"tag-37","9":"tag-gmp","10":"tag-production","11":"category_press-clinical-fr","12":"year_press-47"},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.3.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>31 octobre 2023 : MaaT Pharma pr\u00e9sente des donn\u00e9es pr\u00e9cliniques au SITC pour MaaT034, produit g\u00e9n\u00e9r\u00e9 par intelligence artificielle pour am\u00e9liorer les r\u00e9ponses des patients aux immunoth\u00e9rapies - MaaT Pharma<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"31 octobre 2023 : MaaT Pharma pr\u00e9sente des donn\u00e9es pr\u00e9cliniques au SITC pour MaaT034, produit g\u00e9n\u00e9r\u00e9 par intelligence artificielle pour am\u00e9liorer les r\u00e9ponses des patients aux immunoth\u00e9rapies - MaaT Pharma\" \/>\n<meta property=\"og:description\" content=\"[vc_row type=\u00a0\u00bbin_container\u00a0\u00bb full_screen_row_position=\u00a0\u00bbmiddle\u00a0\u00bb column_margin=\u00a0\u00bbdefault\u00a0\u00bb column_direction=\u00a0\u00bbdefault\u00a0\u00bb column_direction_tablet=\u00a0\u00bbdefault\u00a0\u00bb column_direction_phone=\u00a0\u00bbdefault\u00a0\u00bb scene_position=\u00a0\u00bbcenter\u00a0\u00bb text_color=\u00a0\u00bbdark\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb row_border_radius=\u00a0\u00bbnone\u00a0\u00bb row_border_radius_applies=\u00a0\u00bbbg\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb shape_divider_position=\u00a0\u00bbbottom\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb][vc_column column_padding=\u00a0\u00bbno-extra-padding\u00a0\u00bb column_padding_tablet=\u00a0\u00bbinherit\u00a0\u00bb column_padding_phone=\u00a0\u00bbinherit\u00a0\u00bb column_padding_position=\u00a0\u00bball\u00a0\u00bb column_element_spacing=\u00a0\u00bbdefault\u00a0\u00bb background_color_opacity=\u00a0\u00bb1&Prime; background_hover_color_opacity=\u00a0\u00bb1&Prime; column_shadow=\u00a0\u00bbnone\u00a0\u00bb column_border_radius=\u00a0\u00bbnone\u00a0\u00bb column_link_target=\u00a0\u00bb_self\u00a0\u00bb gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; width=\u00a0\u00bb1\/6&Prime; tablet_width_inherit=\u00a0\u00bbdefault\u00a0\u00bb...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/maat.swebwp.oci.eu\/october-31-2023-maat-pharma-to-present-preclinical-data-at-sitc-on-maat034-an-artificial-intelligence-generated-product-aimed-at-improving-patients-responses-to-immunotherapies\/\" \/>\n<meta property=\"og:site_name\" content=\"MaaT Pharma\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-31T17:04:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/maat.swebwp.oci.eu\/wp-content\/uploads\/2021\/12\/Website_maat_logo.png\" \/>\n\t<meta property=\"og:image:width\" content=\"2362\" \/>\n\t<meta property=\"og:image:height\" content=\"2362\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"MaaT Pharma\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"MaaT Pharma\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/maat.swebwp.oci.eu\/october-31-2023-maat-pharma-to-present-preclinical-data-at-sitc-on-maat034-an-artificial-intelligence-generated-product-aimed-at-improving-patients-responses-to-immunotherapies\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/maat.swebwp.oci.eu\/october-31-2023-maat-pharma-to-present-preclinical-data-at-sitc-on-maat034-an-artificial-intelligence-generated-product-aimed-at-improving-patients-responses-to-immunotherapies\/\"},\"author\":{\"name\":\"MaaT Pharma\",\"@id\":\"https:\/\/maat.swebwp.oci.eu\/#\/schema\/person\/2a1b26915c84fdbc8c7a8ebe36530d34\"},\"headline\":\"31 octobre 2023 : MaaT Pharma pr\u00e9sente des donn\u00e9es pr\u00e9cliniques au SITC pour MaaT034, produit g\u00e9n\u00e9r\u00e9 par intelligence artificielle pour am\u00e9liorer les r\u00e9ponses des patients aux immunoth\u00e9rapies\",\"datePublished\":\"2023-10-31T17:04:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/maat.swebwp.oci.eu\/october-31-2023-maat-pharma-to-present-preclinical-data-at-sitc-on-maat034-an-artificial-intelligence-generated-product-aimed-at-improving-patients-responses-to-immunotherapies\/\"},\"wordCount\":2463,\"publisher\":{\"@id\":\"https:\/\/maat.swebwp.oci.eu\/#organization\"},\"image\":{\"@id\":\"https:\/\/maat.swebwp.oci.eu\/october-31-2023-maat-pharma-to-present-preclinical-data-at-sitc-on-maat034-an-artificial-intelligence-generated-product-aimed-at-improving-patients-responses-to-immunotherapies\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/maat.swebwp.oci.eu\/wp-content\/uploads\/2021\/12\/Website_maat_logo.png\",\"keywords\":[\"2023\",\"GMP\",\"Production\"],\"articleSection\":[\"Communiqu\u00e9s de presse\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/maat.swebwp.oci.eu\/october-31-2023-maat-pharma-to-present-preclinical-data-at-sitc-on-maat034-an-artificial-intelligence-generated-product-aimed-at-improving-patients-responses-to-immunotherapies\/\",\"url\":\"https:\/\/maat.swebwp.oci.eu\/october-31-2023-maat-pharma-to-present-preclinical-data-at-sitc-on-maat034-an-artificial-intelligence-generated-product-aimed-at-improving-patients-responses-to-immunotherapies\/\",\"name\":\"31 octobre 2023 : MaaT Pharma pr\u00e9sente des donn\u00e9es pr\u00e9cliniques au SITC pour MaaT034, produit g\u00e9n\u00e9r\u00e9 par intelligence artificielle pour am\u00e9liorer les r\u00e9ponses des patients aux immunoth\u00e9rapies - MaaT Pharma\",\"isPartOf\":{\"@id\":\"https:\/\/maat.swebwp.oci.eu\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/maat.swebwp.oci.eu\/october-31-2023-maat-pharma-to-present-preclinical-data-at-sitc-on-maat034-an-artificial-intelligence-generated-product-aimed-at-improving-patients-responses-to-immunotherapies\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/maat.swebwp.oci.eu\/october-31-2023-maat-pharma-to-present-preclinical-data-at-sitc-on-maat034-an-artificial-intelligence-generated-product-aimed-at-improving-patients-responses-to-immunotherapies\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/maat.swebwp.oci.eu\/wp-content\/uploads\/2021\/12\/Website_maat_logo.png\",\"datePublished\":\"2023-10-31T17:04:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/maat.swebwp.oci.eu\/october-31-2023-maat-pharma-to-present-preclinical-data-at-sitc-on-maat034-an-artificial-intelligence-generated-product-aimed-at-improving-patients-responses-to-immunotherapies\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/maat.swebwp.oci.eu\/october-31-2023-maat-pharma-to-present-preclinical-data-at-sitc-on-maat034-an-artificial-intelligence-generated-product-aimed-at-improving-patients-responses-to-immunotherapies\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/maat.swebwp.oci.eu\/october-31-2023-maat-pharma-to-present-preclinical-data-at-sitc-on-maat034-an-artificial-intelligence-generated-product-aimed-at-improving-patients-responses-to-immunotherapies\/#primaryimage\",\"url\":\"https:\/\/maat.swebwp.oci.eu\/wp-content\/uploads\/2021\/12\/Website_maat_logo.png\",\"contentUrl\":\"https:\/\/maat.swebwp.oci.eu\/wp-content\/uploads\/2021\/12\/Website_maat_logo.png\",\"width\":1080,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/maat.swebwp.oci.eu\/october-31-2023-maat-pharma-to-present-preclinical-data-at-sitc-on-maat034-an-artificial-intelligence-generated-product-aimed-at-improving-patients-responses-to-immunotherapies\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/maat.swebwp.oci.eu\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"31 octobre 2023 : MaaT Pharma pr\u00e9sente des donn\u00e9es pr\u00e9cliniques au SITC pour MaaT034, produit g\u00e9n\u00e9r\u00e9 par intelligence artificielle pour am\u00e9liorer les r\u00e9ponses des patients aux immunoth\u00e9rapies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/maat.swebwp.oci.eu\/#website\",\"url\":\"https:\/\/maat.swebwp.oci.eu\/\",\"name\":\"MaaT Pharma\",\"description\":\"microbiota gut to fight cancer\",\"publisher\":{\"@id\":\"https:\/\/maat.swebwp.oci.eu\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/maat.swebwp.oci.eu\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/maat.swebwp.oci.eu\/#organization\",\"name\":\"Maat Pharma\",\"url\":\"https:\/\/maat.swebwp.oci.eu\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/maat.swebwp.oci.eu\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/preprod-wadesign.fr\/maat-pharma\/wp-content\/uploads\/2018\/09\/maat-logo-rvb-header.png\",\"contentUrl\":\"http:\/\/preprod-wadesign.fr\/maat-pharma\/wp-content\/uploads\/2018\/09\/maat-logo-rvb-header.png\",\"width\":150,\"height\":171,\"caption\":\"Maat Pharma\"},\"image\":{\"@id\":\"https:\/\/maat.swebwp.oci.eu\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/maat.swebwp.oci.eu\/#\/schema\/person\/2a1b26915c84fdbc8c7a8ebe36530d34\",\"name\":\"MaaT Pharma\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"31 octobre 2023 : MaaT Pharma pr\u00e9sente des donn\u00e9es pr\u00e9cliniques au SITC pour MaaT034, produit g\u00e9n\u00e9r\u00e9 par intelligence artificielle pour am\u00e9liorer les r\u00e9ponses des patients aux immunoth\u00e9rapies - MaaT Pharma","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"fr_FR","og_type":"article","og_title":"31 octobre 2023 : MaaT Pharma pr\u00e9sente des donn\u00e9es pr\u00e9cliniques au SITC pour MaaT034, produit g\u00e9n\u00e9r\u00e9 par intelligence artificielle pour am\u00e9liorer les r\u00e9ponses des patients aux immunoth\u00e9rapies - MaaT Pharma","og_description":"[vc_row type=\u00a0\u00bbin_container\u00a0\u00bb full_screen_row_position=\u00a0\u00bbmiddle\u00a0\u00bb column_margin=\u00a0\u00bbdefault\u00a0\u00bb column_direction=\u00a0\u00bbdefault\u00a0\u00bb column_direction_tablet=\u00a0\u00bbdefault\u00a0\u00bb column_direction_phone=\u00a0\u00bbdefault\u00a0\u00bb scene_position=\u00a0\u00bbcenter\u00a0\u00bb text_color=\u00a0\u00bbdark\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb row_border_radius=\u00a0\u00bbnone\u00a0\u00bb row_border_radius_applies=\u00a0\u00bbbg\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb shape_divider_position=\u00a0\u00bbbottom\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb][vc_column column_padding=\u00a0\u00bbno-extra-padding\u00a0\u00bb column_padding_tablet=\u00a0\u00bbinherit\u00a0\u00bb column_padding_phone=\u00a0\u00bbinherit\u00a0\u00bb column_padding_position=\u00a0\u00bball\u00a0\u00bb column_element_spacing=\u00a0\u00bbdefault\u00a0\u00bb background_color_opacity=\u00a0\u00bb1&Prime; background_hover_color_opacity=\u00a0\u00bb1&Prime; column_shadow=\u00a0\u00bbnone\u00a0\u00bb column_border_radius=\u00a0\u00bbnone\u00a0\u00bb column_link_target=\u00a0\u00bb_self\u00a0\u00bb gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; width=\u00a0\u00bb1\/6&Prime; tablet_width_inherit=\u00a0\u00bbdefault\u00a0\u00bb...","og_url":"https:\/\/maat.swebwp.oci.eu\/october-31-2023-maat-pharma-to-present-preclinical-data-at-sitc-on-maat034-an-artificial-intelligence-generated-product-aimed-at-improving-patients-responses-to-immunotherapies\/","og_site_name":"MaaT Pharma","article_published_time":"2023-10-31T17:04:10+00:00","og_image":[{"width":2362,"height":2362,"url":"https:\/\/maat.swebwp.oci.eu\/wp-content\/uploads\/2021\/12\/Website_maat_logo.png","type":"image\/png"}],"author":"MaaT Pharma","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"MaaT Pharma","Dur\u00e9e de lecture estim\u00e9e":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/maat.swebwp.oci.eu\/october-31-2023-maat-pharma-to-present-preclinical-data-at-sitc-on-maat034-an-artificial-intelligence-generated-product-aimed-at-improving-patients-responses-to-immunotherapies\/#article","isPartOf":{"@id":"https:\/\/maat.swebwp.oci.eu\/october-31-2023-maat-pharma-to-present-preclinical-data-at-sitc-on-maat034-an-artificial-intelligence-generated-product-aimed-at-improving-patients-responses-to-immunotherapies\/"},"author":{"name":"MaaT Pharma","@id":"https:\/\/maat.swebwp.oci.eu\/#\/schema\/person\/2a1b26915c84fdbc8c7a8ebe36530d34"},"headline":"31 octobre 2023 : MaaT Pharma pr\u00e9sente des donn\u00e9es pr\u00e9cliniques au SITC pour MaaT034, produit g\u00e9n\u00e9r\u00e9 par intelligence artificielle pour am\u00e9liorer les r\u00e9ponses des patients aux immunoth\u00e9rapies","datePublished":"2023-10-31T17:04:10+00:00","mainEntityOfPage":{"@id":"https:\/\/maat.swebwp.oci.eu\/october-31-2023-maat-pharma-to-present-preclinical-data-at-sitc-on-maat034-an-artificial-intelligence-generated-product-aimed-at-improving-patients-responses-to-immunotherapies\/"},"wordCount":2463,"publisher":{"@id":"https:\/\/maat.swebwp.oci.eu\/#organization"},"image":{"@id":"https:\/\/maat.swebwp.oci.eu\/october-31-2023-maat-pharma-to-present-preclinical-data-at-sitc-on-maat034-an-artificial-intelligence-generated-product-aimed-at-improving-patients-responses-to-immunotherapies\/#primaryimage"},"thumbnailUrl":"https:\/\/maat.swebwp.oci.eu\/wp-content\/uploads\/2021\/12\/Website_maat_logo.png","keywords":["2023","GMP","Production"],"articleSection":["Communiqu\u00e9s de presse"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/maat.swebwp.oci.eu\/october-31-2023-maat-pharma-to-present-preclinical-data-at-sitc-on-maat034-an-artificial-intelligence-generated-product-aimed-at-improving-patients-responses-to-immunotherapies\/","url":"https:\/\/maat.swebwp.oci.eu\/october-31-2023-maat-pharma-to-present-preclinical-data-at-sitc-on-maat034-an-artificial-intelligence-generated-product-aimed-at-improving-patients-responses-to-immunotherapies\/","name":"31 octobre 2023 : MaaT Pharma pr\u00e9sente des donn\u00e9es pr\u00e9cliniques au SITC pour MaaT034, produit g\u00e9n\u00e9r\u00e9 par intelligence artificielle pour am\u00e9liorer les r\u00e9ponses des patients aux immunoth\u00e9rapies - MaaT Pharma","isPartOf":{"@id":"https:\/\/maat.swebwp.oci.eu\/#website"},"primaryImageOfPage":{"@id":"https:\/\/maat.swebwp.oci.eu\/october-31-2023-maat-pharma-to-present-preclinical-data-at-sitc-on-maat034-an-artificial-intelligence-generated-product-aimed-at-improving-patients-responses-to-immunotherapies\/#primaryimage"},"image":{"@id":"https:\/\/maat.swebwp.oci.eu\/october-31-2023-maat-pharma-to-present-preclinical-data-at-sitc-on-maat034-an-artificial-intelligence-generated-product-aimed-at-improving-patients-responses-to-immunotherapies\/#primaryimage"},"thumbnailUrl":"https:\/\/maat.swebwp.oci.eu\/wp-content\/uploads\/2021\/12\/Website_maat_logo.png","datePublished":"2023-10-31T17:04:10+00:00","breadcrumb":{"@id":"https:\/\/maat.swebwp.oci.eu\/october-31-2023-maat-pharma-to-present-preclinical-data-at-sitc-on-maat034-an-artificial-intelligence-generated-product-aimed-at-improving-patients-responses-to-immunotherapies\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/maat.swebwp.oci.eu\/october-31-2023-maat-pharma-to-present-preclinical-data-at-sitc-on-maat034-an-artificial-intelligence-generated-product-aimed-at-improving-patients-responses-to-immunotherapies\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/maat.swebwp.oci.eu\/october-31-2023-maat-pharma-to-present-preclinical-data-at-sitc-on-maat034-an-artificial-intelligence-generated-product-aimed-at-improving-patients-responses-to-immunotherapies\/#primaryimage","url":"https:\/\/maat.swebwp.oci.eu\/wp-content\/uploads\/2021\/12\/Website_maat_logo.png","contentUrl":"https:\/\/maat.swebwp.oci.eu\/wp-content\/uploads\/2021\/12\/Website_maat_logo.png","width":1080,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/maat.swebwp.oci.eu\/october-31-2023-maat-pharma-to-present-preclinical-data-at-sitc-on-maat034-an-artificial-intelligence-generated-product-aimed-at-improving-patients-responses-to-immunotherapies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/maat.swebwp.oci.eu\/fr\/"},{"@type":"ListItem","position":2,"name":"31 octobre 2023 : MaaT Pharma pr\u00e9sente des donn\u00e9es pr\u00e9cliniques au SITC pour MaaT034, produit g\u00e9n\u00e9r\u00e9 par intelligence artificielle pour am\u00e9liorer les r\u00e9ponses des patients aux immunoth\u00e9rapies"}]},{"@type":"WebSite","@id":"https:\/\/maat.swebwp.oci.eu\/#website","url":"https:\/\/maat.swebwp.oci.eu\/","name":"MaaT Pharma","description":"microbiota gut to fight cancer","publisher":{"@id":"https:\/\/maat.swebwp.oci.eu\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/maat.swebwp.oci.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/maat.swebwp.oci.eu\/#organization","name":"Maat Pharma","url":"https:\/\/maat.swebwp.oci.eu\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/maat.swebwp.oci.eu\/#\/schema\/logo\/image\/","url":"http:\/\/preprod-wadesign.fr\/maat-pharma\/wp-content\/uploads\/2018\/09\/maat-logo-rvb-header.png","contentUrl":"http:\/\/preprod-wadesign.fr\/maat-pharma\/wp-content\/uploads\/2018\/09\/maat-logo-rvb-header.png","width":150,"height":171,"caption":"Maat Pharma"},"image":{"@id":"https:\/\/maat.swebwp.oci.eu\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/maat.swebwp.oci.eu\/#\/schema\/person\/2a1b26915c84fdbc8c7a8ebe36530d34","name":"MaaT Pharma"}]}},"_links":{"self":[{"href":"https:\/\/maat.swebwp.oci.eu\/fr\/wp-json\/wp\/v2\/posts\/11280","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/maat.swebwp.oci.eu\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/maat.swebwp.oci.eu\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/maat.swebwp.oci.eu\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/maat.swebwp.oci.eu\/fr\/wp-json\/wp\/v2\/comments?post=11280"}],"version-history":[{"count":0,"href":"https:\/\/maat.swebwp.oci.eu\/fr\/wp-json\/wp\/v2\/posts\/11280\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/maat.swebwp.oci.eu\/fr\/wp-json\/wp\/v2\/media\/7120"}],"wp:attachment":[{"href":"https:\/\/maat.swebwp.oci.eu\/fr\/wp-json\/wp\/v2\/media?parent=11280"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/maat.swebwp.oci.eu\/fr\/wp-json\/wp\/v2\/categories?post=11280"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/maat.swebwp.oci.eu\/fr\/wp-json\/wp\/v2\/tags?post=11280"},{"taxonomy":"category_press","embeddable":true,"href":"https:\/\/maat.swebwp.oci.eu\/fr\/wp-json\/wp\/v2\/category_press?post=11280"},{"taxonomy":"year_press","embeddable":true,"href":"https:\/\/maat.swebwp.oci.eu\/fr\/wp-json\/wp\/v2\/year_press?post=11280"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}